Download Citation
Article Source:
Development and evaluation of inhalable composite niclosamide-lysozyme particles: A broad-spectrum, patient-adaptable treatment for coronavirus infections and sequalae
Brunaugh AD,
Seo H,
Warnken Z,
Ding L,
Seo SH,
et al.
(2021)
Development and evaluation of inhalable composite niclosamide-lysozyme particles: A broad-spectrum, patient-adaptable treatment for coronavirus infections and sequalae.
PLOS ONE 16(2): e0246803.
https://doi.org/10.1371/journal.pone.0246803